Evaluation of the effect of Botulinum Toxin as a treatment for Male Pattern Baldness

Not Applicable

• Conditions: Androgenetic Alopecia; C17.800.329.937

• Registration Number: RBR-5z2rr58
• Lead Sponsor: Faculdade de Ciências Médicas - Universidade do Estado do Rio de Janeiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-20
• Last Update Posted: 29 May 2023
• Study Completion: 2023-06-19

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Male patients; androgenetic alopecia diagnosis; involvement of the vertex and frontotemporal recesses; age between 20 and 35 years; less than 5 years of disease evolution; all ethnicities and prototypes; patients who never used a treatment and patients who have not used medication for at least six months.

Exclusion Criteria

Individuals outside the age range defined for the research; evolution of disease greater than 5 years; women as this is a study aimed at a male audience. Patients with other inflammatory; patients with infectious or tumor conditions concomitant with androgenetic alopecia that affect the scalp and patients undergoing treatment for androgenetic alopecia.

Study & Design

• Study Type: Intervention
• Study Design: Not specified